We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XRX icon
376
PUT
Xerox
XRX
$361M
$552K 0.01%
248,800
– –
2021 Q2
9 quarters
ORTX
377
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$551K 0.01%
71,010
– –
2022 Q1
6 quarters
ZTO icon
378
ZTO Express
ZTO
$15.1B
$544K 0.01%
22,490
-6,310
-22% -$161K
2021 Q2
9 quarters
EPRT icon
379
Essential Properties Realty Trust
EPRT
$5.49B
$541K 0.01%
+25,000
New +$596K
2023 Q3
0 quarters
LCA
380
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$528K 0.01%
50,644
– –
2021 Q2
9 quarters
CCI icon
381
Crown Castle
CCI
$33.9B
$525K 0.01%
5,700
-73,638
-93% -$7.63M
2021 Q3
8 quarters
ORCL icon
382
Oracle
ORCL
$429B
$522K 0.01%
4,926
+2,933
+147% +$339K
2023 Q2
1 quarter
PCVX icon
383
Vaxcyte
PCVX
$11.2B
$510K 0.01%
+10,000
New +$493K
2023 Q3
0 quarters
ICLR icon
384
Icon
ICLR
$12.7B
$504K 0.01%
2,045
-4,100
-67% -$1.03M
2022 Q2
5 quarters
KLRS icon
385
Kalaris Therapeutics
KLRS
$56.2M
$495K 0.01%
10,000
+2,609
+35% +$178K
2023 Q2
1 quarter
THRX
386
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$488K 0.01%
181,452
+60,000
+49% +$235K
2023 Q1
2 quarters
NERV icon
387
Minerva Neurosciences
NERV
$152M
$483K 0.01%
+70,000
New +$627K
2023 Q3
0 quarters
SNOW icon
388
Snowflake
SNOW
$130B
$473K 0.01%
3,098
-5,707
-65% -$929K
2023 Q2
1 quarter
CNTB icon
389
Connect Biopharma Holdings
CNTB
$54.8M
$469K 0.01%
603,900
– –
2022 Q2
5 quarters
HROW icon
390
Harrow
HROW
$1.1B
$467K 0.01%
+32,508
New +$568K
2023 Q3
0 quarters
AGNC icon
391
AGNC Investment
AGNC
$10.3B
$467K 0.01%
49,419
-15,962
-24% -$158K
2023 Q1
2 quarters
ACRS icon
392
Aclaris Therapeutics
ACRS
$564M
$466K 0.01%
68,014
-5,000
-7% -$42.7K
2022 Q1
6 quarters
DTIL icon
393
Precision BioSciences
DTIL
$185M
$456K 0.01%
44,610
– –
2022 Q2
5 quarters
CNTX icon
394
Context Therapeutics
CNTX
$27.9M
$447K 0.01%
295,700
+230,072
+351% +$260K
2023 Q2
1 quarter
BNTX icon
395
BioNTech
BNTX
$24.4B
$435K 0.01%
+4,000
New +$442K
2023 Q3
0 quarters
UBX icon
396
DELISTED
Unity Biotechnology
UBX
$430K 0.01%
179,080
– –
2022 Q3
4 quarters
SONO icon
397
Sonos
SONO
$2.04B
$420K 0.01%
+32,500
New +$482K
2023 Q3
0 quarters
NAMS icon
398
NewAmsterdam Pharma
NAMS
$2.58B
$416K 0.01%
+45,000
New +$487K
2023 Q3
0 quarters
GLUE icon
399
Monte Rosa Therapeutics
GLUE
$879M
$409K 0.01%
85,478
-15,000
-15% -$96.6K
2022 Q1
6 quarters
EDR icon
400
DELISTED
Endeavor Group Holdings, Inc.
EDR
$398K 0.01%
+20,000
New +$459K
2023 Q3
0 quarters
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.